TBIO - Telesis Bio Inc
IEX Last Trade
3.43
0.070 2.041%
Share volume: 40,605
Last Updated: Fri 30 Aug 2024 04:53:43 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$3.36
0.07
2.08%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-11 | 2022-08-10 | 2022-11-09 | 2023-03-22 | 2023-05-12 | 2023-08-11 | 2023-11-13 | |
| Total revenue | 5.636 M | 5.655 M | 6.675 M | 9.469 M | 6.316 M | 8.652 M | 5.564 M | |
| Cost of revenue | 2.858 M | 2.943 M | 3.016 M | 3.023 M | 2.805 M | 2.959 M | 2.567 M | |
| Gross profit | 2.778 M | 2.712 M | 3.659 M | 6.446 M | 3.511 M | 5.693 M | 2.997 M | |
| -2.38% | 34.92% | 76.17% | -45.53% | 62.15% | -47.36% | |||
| Operating expenses | 15.641 M | 17.199 M | 14.910 M | 14.330 M | 14.482 M | 13.659 M | 13.118 M | |
| Selling general and admin | 9.260 M | 10.075 M | 9.094 M | 10.191 M | 9.361 M | 9.072 M | 8.999 M | |
| Research and development | 6.381 M | 7.124 M | 5.816 M | 4.139 M | 5.121 M | 4.587 M | 4.119 M | |
| Total expenses | 18.499 M | 20.142 M | 17.926 M | 17.353 M | 17.287 M | 16.618 M | 15.685 M | |
| 8.88% | -11.00% | -3.20% | -0.38% | -3.87% | -5.61% | |||
| Operating income | -12.863 M | -14.487 M | -11.251 M | -7.884 M | -10.971 M | -7.966 M | -10.121 M | |
| Ebit | -12.863 M | -14.487 M | -11.251 M | -7.884 M | -10.971 M | -7.966 M | -10.121 M | |
| Pretax income | -13.188 M | -14.825 M | -12.308 M | -8.126 M | -11.116 M | -8.283 M | -10.617 M | |
| 12.41% | -16.98% | -33.98% | 36.80% | -25.49% | 28.18% | |||
| Income tax | 6.000 K | 6.000 K | 6.000 K | 6.000 K | 3.000 K | 4.000 K | 14.000 K | |
| Net income basic | -13.194 M | -14.831 M | -12.314 M | -8.132 M | -11.119 M | -8.440 M | -11.199 M | |
| -12.41% | 16.97% | 33.96% | -36.73% | 24.09% | -32.69% | |||
| Net income | -13.194 M | -14.831 M | -12.314 M | -8.132 M | -11.119 M | -8.440 M | -11.199 M | |
| -12.41% | 16.97% | 33.96% | -36.73% | 24.09% | -32.69% |